Skip to search formSkip to main contentSkip to account menu

IDegLira

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Drug CombinationsInsulin, Long-Actingliraglutide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Author response for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese…
2019
2019
Author response for "Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with ≤50 units insulin degludec in Japanese subjects with type 2…
2019
2019
Author response for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL…
Review
2019
Review
2019
Review for "Superior efficacy with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese subjects with…
2018
2018
Patients with Type 2 Diabetes (T2D) on the Maximum Dose of Insulin Degludec/Liraglutide (IDegLira) Achieve Glycemic Target—Analyses from the DUAL Program
The efficacy and safety of IDegLira has been established in the DUAL clinical development program. This post-hoc analysis… 
2017
2017
Patient-reported outcomes with insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial
2015
2015
23. Insulin Degludec/Liraglutide (IDegLira) Is Superior to Insulin Glargine (IG) in A1c Reduction, Risk of Hypoglycemia, and Weight Change: DUAL V Study (166-OR)
SamenvattingThis 26-week, open-label trial compared the efficacy and safety of IDegLira vs. IG in subjects with type 2 diabetes… 
2015
2015
IDegLira, eine Fixkombination aus Insulin degludec und Liraglutid, verbessert sowohl die prä- als auch die postprandiale Plasmaglucose bei Patienten mit Typ 2 Diabetes
2015
2015
Verbesserte postprandiale Blutzuckereinstellung bei Typ 2 Diabetes mit einer Fikombination von Insulin degludec und Liraglutid: Ergebnisse eines Mahlzeitentests
Hintergrund: IDegLira wurde mit IDeg oder Lira allein hinsichtlich des postprandialen Blutzuckers verglichen. Methoden: 1663… 
2015
2015
The place of IDegLira in the management of patients with Type 2 diabetes
Type 2 diabetes mellitus is a progressive disease and this means that treatment intensification is needed to achieve glycemic…